<GlossaryTerm id="CDR0000045014"><TermName>MS-275</TermName><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancers of the blood. It belongs to the family of drugs called histone deacetylase inhibitors.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>MS-275</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de los cánceres de la sangre. Es un tipo de inhibidor de la histona–desacetilasa.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2003-12-01</DateLastModified></GlossaryTerm>
